Companies / Coherus Oncology, Inc.

Coherus Oncology, Inc.

Nasdaq: CHRSCIK 1512762REDWOOD CITY, CAcoherus.com

Financials · FY2019

Revenue$123.86M
Net income$168.02M
Total debt$73.66M
Cash$82.92M
Diluted EPS$1.43
Shares outstanding154.5M

Ownership

154.5M shares outstanding · as of Jul 31, 2026
0.77%Insiders
Ownership
Insiders0.77%1,181,971
10%+ / strategic6.49%10,028,893
Institutions37.71%58,264,642
Public float55.03%85,025,460

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Lanfear Dennis MCEOPresident & CEO · Director
0.68%1,048,235
McMichael Bryan JChief Financial Officer
0.09%133,736

Institutional holders 133

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 20, 2026Lanfear Dennis M
CEO
OtherCommon Stock$18.4K-12K
-1.73%
673,235
0.44% of shares
low
Jan 20, 2026McMichael Bryan J
Executive
OtherCommon Stock$2.7K-2K
-7.47%
21,236
0.01% of shares
low
Jan 23, 2026Lanfear Dennis M
CEO
GrantCommon Stock$0+375K
+55.70%
1,048,235
0.68% of shares
low
Jan 22, 2026McMichael Bryan J
Executive
GrantCommon Stock$0+113K
+529.76%
133,736
0.09% of shares
low
Jan 23, 2026Lanfear Dennis M
CEO
GrantStock Option (Right to Buy)+750K
750,000
0.49% of shares
low
Jan 22, 2026McMichael Bryan J
Executive
GrantStock Option (Right to Buy)+225K
225,000
0.15% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A10,028,893
Vanguard Group IncPassive13G/A0
Timothy G. Youngquist 2020 Irrevocable TrustPassive13G
Thomas A. Satterfield, Jr.Passive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CHRS19249H103